Avacta has raised £10 million in an oversubscribed placing and subscription to extend runway into early 2027 and advance its pre|CISION platform, including programmes in triple negative breast cancer.
"The Board’s decision to raise funds enables Avacta to continue to retain 100% ownership of our highly promising programs. We believe this decision to overwhelmingly be in the long-term interest of shareholders, such is the potential for our proprietary technology." — Christina Coughlin, CEO, Avacta
OnKure has raised $150 million to accelerate development of its precision oncology pipeline, including programmes targeting breast cancer. The funding will support clinical advancement of its PI3Kα inhibitor and broader efforts to improve outcomes in hard-to-treat cancers.
Cibra Capital has acquired a new position in Hologic worth approximately $4.68 million, according to the article text. That matters because the URL references $37.81 million holdings, but the article itself describes a newly purchased stake valued at the lower figure.
Coral has raised an additional CAD $4 million in acceleration funding, bringing total capital raised to more than CAD $8 million, as it expands virtual menopause and midlife care in Canada.
“For too long, menopause has been addressed as a series of isolated symptoms rather than a complex metabolic and hormonal transition. Unlike fragmented, prescription-led telehealth services for women that focus only on symptoms, Coral delivers an integrated clinical model designed to combine lifestyle and medical interventions, to help women optimize their health for the long term and truly thrive.” — Fiona Lake Waslander, CEO & Cofounder, Coral
Ontario startup myStoria has raised $1.625 million to scale its platform supporting patients across PCOS, endometriosis, fertility and perimenopause, combining AI with trained human guidance.
🔗 https://thenextweb.com/news/mystoria-raises-1-625m
The Cancer Vaccine Coalition, through its partnership with the V Foundation, has announced a $1 million grant to support a Phase II study at MD Anderson focused on stopping breast cancer recurrence before it starts.
"Cancer vaccines are a new class of treatment seeing promising results in early studies. We are at a pivotal moment for this research. Trials like this and the partnerships that CVC is building, are designed to help bring groundbreaking therapies to patients sooner." — Kristen Dahlgren, Founder & CEO, Cancer Vaccine Coalition
Organon has named five recipients for its 2026 Her Health Grants across Asia Pacific, supporting community-led initiatives focused on contraception, adolescent sexual and reproductive health, menopause support and women workers’ access to care. The release does not specify the grant amounts.
"These Her Health Grants elevate community leadership and ensure that solutions reflect the realities of the women they serve. At Organon, we listen to women and act with purpose, because healthier women and girls strengthen societies—and we are proud to partner in creating tangible, positive impact." — Andreas Daugaard Jørgensen, Managing Director, Organon Asia Pacific
Garmin users with select smartwatches can now sync with Natural Cycles, extending access to the FDA-cleared birth control app through wrist-based temperature tracking.
WUKA has expanded its Tesco rollout from fewer than 300 stores to more than 1,800 nationwide, including over 1,300 Tesco Express locations, significantly widening access to reusable period products across the UK.
